 Home > Active Ingredient News > Antitumor Therapy > European Radiology: Measurement of this imaging marker predicts chemotherapy-associated steatohepatitis in breast cancer patients receiving NAC!

European Radiology: Measurement of this imaging marker predicts chemotherapy-associated steatohepatitis in breast cancer patients receiving NAC!

 Last Update: 2022-08-19
 Source: Internet
 Author: User

Tags

non calcium antacid

tums calcium content

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

According to statistics, breast cancer (BC) is the most common female cancer worldwid.

The ability of many chemotherapeutic agents to cause steatohepatitis has become more apparent and led to the formation of chemotherapy-associated steatohepatitis (CASH.

The incidence of cardiovascular disease (CVD) is significantly increased in BC patients receiving cardiotoxic chemotherapy drugs such as anthracyclines, cyclophosphamide, and trastuzuma.

A study published in European Radiology recently quantified liver fat content by MRI mDIXON-Quant examination to determine the prevalence of CASH, and semi-automated volume analysis software to measure EAT volume on chest CT to explore BC patients after NA.

This study reviewed enrolled patients from October 2018 to April 2020 and divided them into breast cancer non-NAC and NAC group.

A total of 662 breast cancer patients were included (non-NAC group: 445; NAC group: 217.

The present study found that in BC patients receiving NAC, the prevalence of CASH was 48% and the EAT volume was significantly increase.

Original source:

Xiaoxia Wang, Yuchuan Tan, Daihong Liu, et a.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.